Categories AlphaGraphs, Earnings, Health Care

Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today.

Total revenues increased 8% year-over-year to $11.9 billion. Revenues grew 10%, excluding FX.

Net earnings attributable to BMS were $1.21 billion, or $0.60 per share, compared to $1.92 billion, or $0.93 per share, last year. Adjusted EPS decreased 10% to $1.80.

For the full year of 2024, BMY expects total revenues to increase around 5% YoY. Adjusted EPS is expected to be $0.75-0.95.

Prior performance

Bristol-Myers Squibb Company Q2 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Altria (MO) Q3 2024 Earnings: Key financials and quarterly highlights

Altria Group, Inc. (NYSE: MO) reported its third quarter 2024 earnings results today. Net revenues remained relatively unchanged at $6.25 billion compared to the same period a year ago. Net

Main highlights from Estee Lauder’s (EL) Q1 2025 earnings results

The Estee Lauder Companies Inc. (NYSE: EL) reported its first quarter 2025 earnings results today. Net sales were $3.36 billion, down 4% from the prior-year period. Organic net sales decreased

MSFT Earnings: Highlights of Microsoft’s Q1 2025 report

Microsoft Corp. (NASDAQ: MSFT) reported strong revenues and earnings growth for the first quarter of 2025. The results benefitted from the growing demand for the tech giant's cloud services. First-quarter

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top